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Abstract 
Background 
A substantial part of the risk for alcohol use disorder (AUD) is determined by 
genetic factors. We previously used chromosome substitution (CSS) mice, to 
identify a QTL for alcohol preference on mouse chromosome 2. The aim of this 
study was to identify candidate genes within this QTL that confer the risk for 
alcohol preference.  
Methods 
In order to delineate the neurobiological underpinnings of alcohol consumption, 
we expanded on the QTL approach to identify candidate genes for high alcohol 
preference in mice. We narrowed down a QTL for alcohol preference on mouse 
chromosome 2, that we previously identified using chromosome substitution 
(CSS) mice, to four candidate genes in silico. Expression levels of these 
candidate genes in prefrontal cortex, amygdala and nucleus accumbens, brain 
regions implicated in reward and addiction, were subsequently compared for the 
CSS-2 and the C57BL/6J host strain.  
Results  
We observed increased expression of adenosine deaminase-like (Adal) in all 
three regions in CSS-2 mice. Moreover, we found that the adenosine deaminase 
inhibitor EHNA reduced the difference in alcohol preference between CSS-2 and 
C57Bl/6J mice.  
Conclusion  
The current study identifies Adal as a genetically protective factor against alcohol 
consumption in mice, in which elevated Adal levels contribute to low alcohol 
preference.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Keywords adenosine, alcohol, QTL, preference, mice 
 
Introduction  
Alcohol use disorders (AUD) are an enormous public health problem, affecting 
over 76 million people worldwide (WHO, 2011). The risk for AUD is determined 
for a substantial part by genetic factors. Twin and adoption studies have 
demonstrated greater risk for alcohol-related disorders in individuals who have 
an affected monozygotic twin, as compared to individuals with an affected 
dizygotic twin (Ystrom et al., 2011). From these studies, the heritability for AUD 
has been estimated to be 48-71%.  
 
Human genome wide association studies (GWAS) and rodent genetic mapping 
studies have yielded profound insight into the molecular mechanisms underlying 
the individual risk for AUD. For example, inbred mouse strains, which are well 
characterized both genetically and behaviorally, have been used to discern the 
genetic components underlying the vulnerability for AUD. Indeed, multiple 
quantitative trait loci (QTL) for alcohol intake and/or preference have been 
identified (Bubier et al., 2014; Gill and Boyle, 2005; Lesscher et al., 2009a; 
Phillips et al., 1998; Rodriguez et al., 1995; Vadasz et al., 2000; Whatley et al., 
1999). In-depth QTL analyses have revealed specific genes that contribute to the 
risk for alcohol consumption and AUD (Bubier et al., 2014; Milner and Buck, 
2010).  
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We previously used chromosome substitution (CSS) mice (Nadeau et al., 2000), 
to identify a grandparent-dependent QTL for alcohol preference on mouse 
chromosome 2. Chromosome 2 was chosen as our focal point because QTLs for 
high alcohol consumption were previously identified on this chromosome. CSS-2 
mice, in which chromosome 2 from the A/J donor strain was introduced into the 
genome of C57BL/6J mice, displayed a low preference for alcohol compared to 
C57BL/6J mice (Lesscher et al., 2009a). CSS-2 were however not different from 
C57BL/6J mice in taste preference for sweet and bitter solutions nor in the 
metabolism rate of alcohol. In this study, we expanded on this QTL approach to 
identify quantitative trait genes (QTG) that confer the risk for alcohol preference. 
Therefore, we narrowed down the QTL on chromosome 2 in silico to identify 
candidate genes. To select QTGs (1) we first selected coding SNPs within the 
QTL, (2) we then selected genes that are expressed in the brain and 
subsequently filtered those genes with expression in brain regions that have 
been associated with reward and addictive behavior, i.e. the PFc, AMG and NAc, 
and (3) we further selected genes for which literature was available to support 
their role in (reward-related) behavior) (Abiola et al., 2003; Korstanje and 
Paigen, 2002; Nikolskiy et al., 2015; Noyes et al., 2011). Subsequently, 
expression levels of these candidate genes in the prefrontal cortex (PFc), 
amygdala (AMG) and nucleus accumbens (NAc), brain regions widely implicated 
in the positive subjective and addictive properties of substances of abuse (e.g. 
Everitt and Robbins, 2013; Koob and Volkow, 2010; Tabakoff and Hoffman, 
2013) were compared for the CSS-2 and C57BL/6J host strain. Finally, using a 
pharmacological approach, the functional role of the most prominent candidate 
gene, adenosine deaminase-like (Adal) in the regulation of alcohol consumption 
in CSS-2 mice was determined.  
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Materials and Methods 
Animals  
C57BL/6J, A/J and C57BL/6J-Chr 2A/NaJ (referred to as CSS-2) (Nadeau et al., 
2000) mice were obtained from Jackson Laboratory (Bar Harbor, Main, USA) and 
bred in our department. Experimental animals were male mice, 8-10 weeks old 
at the onset of testing. The mice were group-housed with mice from the same 
genotype under controlled conditions (20 ± 2ºC and 50-70% humidity) and they 
were acclimatized to a 12-h light/dark cycle (lights off at 7:00 AM) for at least 2 
weeks prior to testing. Food and water were available ad libitum. The 
experimental procedures were approved by the Animal Ethics Committee of 
Utrecht University and were conducted in agreement with Dutch laws (Wet op de 
dierproeven, 1996) and European regulations (Guideline 86/609/EEC). 
 
Narrowing down the QTL and identification of candidate genes 
To narrow down the identified grandparent-dependent QTL for alcohol preference 
on chromosome 2, which ranged from 112 to 134 Mbp (Lesscher et al., 2009a), 
haplotype blocks for the A/J and C57BL/6J host strains were identified using the 
Perlegen Genotype Browser (http://mouse.cs.ucla.edu/perlegen/) within the QTL 
range. This analysis revealed multiple blocks with genetic variation between A/J 
and C57BL/6J mice. Subsequently, coding non-synonymous SNPs within the QTL 
range, i.e. chromosome 2: 112-134 Mbp, were identified by comparing this 
genomic region for A/J and C57BL/6J strains using the Mouse Genome 
Informatics (MGI) Mouse SNP Query 
(http://www.informatics.jax.org/javawi2/servlet/WIFetch?page=snpQF). Finally, 
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to determine which genes are expressed in brain, we aligned the genes within 
the QTL range with the nearly 20,000 genes with reported brain expression of 
the Allen Brain Atlas (http://www.brain-map.org/). The remaining candidate 
genes, identified with this approach, were further explored for their contribution 
to the observed strain differences in alcohol preference based on brain 
expression patterns and reported behavioural effects in the literature. For this 
purpose, we selected genes that were expressed in brain regions that have been 
associated with reward and addictive behavior, i.e. the PFc, AMG and NAc (using 
the Allen Brain Atlas). Subsequently, we selected genes for which literature was 
available to support their role in (reward-related) behavior 
(http://www.informatics.jax.org). Genes that were involved in other processes, 
such as platelet regulation, leukemia, inner ear function, cancer etc. were 
excluded at this stage. With this approach, the QTL range was narrowed down to 
4 candidate genes: Adal (Adenosine deaminase-like), Chrm5 (muscarinic 5 
acetylcholine receptor), Disp2 (Dispatched homolog 2) and Ubr1 (Ubiquitin 
protein ligase E3 component n-recognin 1). 
 
 
Expression analysis of candidate genes in host strains by qPCR 
We reasoned that, if genetic variation in the identified candidate genes, i.e. Adal, 
Chrm5, Disp2 and Ubr1, is relevant for the phenotypical difference in alcohol 
preference between C57BL/6J and CSS-2 mice (Lesscher et al., 2009a), then the 
expression of these genes in reward-related brain regions would differ between 
the two strains. Therefore, to validate their potential role in regulating alcohol 
preference, the expression levels of these candidate genes were compared for 
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C57BL/6J and CSS-2 mice by qPCR analysis. For this purpose, alcohol-naïve 
mice of both genotypes (CSS-2 and C57BL/6J, N = 6) were sacrificed by rapid 
decapitation and brains were dissected, snap frozen on dry ice and stored at -
80°C. PFc, AMG and NAc punch samples were obtained using a 20G punch 
needle and were immersed instantly in RNAlater (Sigma, Germany). Total RNA 
was isolated from these samples using Trizol (Invitrogen, The Netherlands), 
DNAse treated (Ambion, TX, USA) and purified using the RNeasy MinElute 
Cleanup kit (Qiagen N.V., The Netherlands). Subsequently, cDNA was 
synthesized from the RNA samples using oligo-dT primers. qPCR analysis was 
performed using the LightCycler (Roche, The Netherlands), the Fast Start DNA 
Master PLUS SYBRgreen I kit (Roche) and primers listed in Table 1. After initial 
normalization to the housekeeping gene beta-actin, gene expression was 
calculated as the ratio to levels of C57BL/6J mice using the comparative Ct 
method (Lesscher et al., 2012; Schmittgen and Livak, 2008). 
 
 
Limited access ethanol consumption and Adal inhibition 
Because Adal, of the four identified candidate genes, showed most pronounced 
and consistent expression differences between CSS-2 and C57BL/6J mice, we 
next assessed the contribution of enhanced Adal levels to the phenotypic 
difference in alcohol consumption between CSS-2 and C57BL/6J strains. To that 
aim, the Adal inhibitor erythro-9-(2-Hydroxy-3-nonyl)adenine hydrochloride 
(EHNA, Tocris, UK) was used to counteract the augmented Adal activity in CSS-2 
mice. Immediately prior to daily alcohol consumption sessions in the limited 
access choice paradigm, C57BL/6J and CSS-2 mice were treated with either 
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vehicle (saline) or EHNA (10 mg/kg i.p., 2 ml/kg in saline; Tocris, Bristol, UK) (N 
= 8 per strain and treatment). The mice were randomly assigned to the 
treatment groups (saline or EHNA).  
 
The procedures for ethanol consumption were similar to those used previously 
(Lesscher et al., 2009a; 2012). A limited access paradigm using a 15% ethanol 
solution was employed. In with this paradigm, mice readily consume high 
amounts of alcohol and show a gradual increase in alcohol consumption over the 
course of 2-4 weeks (Lesscher et al., 2009b; Lesscher et al., 2012). Moreover, 
using a limited access paradigm with 20% alcohol strain differences in alcohol 
consumption in mice have been demonstrated, including reduced alcohol intake 
in A/J compared to C57BL/6J mice (Rhodes et al., 2007). Importantly, reduced 
alcohol consumption by A/J mice compared to C57BL/6J mice is not dependent 
on the alcohol concentration nor to limited access to alcohol. For example, a 
study by Yoneyama et al. (2008) showed that A/J mice consumed less alcohol 
compared to C57BL/6J mice in a continuous access 2-bottle choice task using 
3%, 6% and 10% alcohol.  
 
The mice were placed in a separate test cage for 2 h starting at 10:00 AM daily 
for three consecutive weeks. The mice received access to two drinking tubes, i.e. 
10 ml polysterene pipettes fitted with a stainless steel ball-bearing sipper tube. 
One tube delivered tap water and the other 15% ethanol (v/v in tap water). 
During the initial 7 days of training, the water and ethanol bottles were on fixed 
locations. Thereafter, the bottle positions were switched daily to avoid side-
preference. Fluid volumes were measured to the nearest 0.05 ml prior to and 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
after each drinking session, by reading the pipette scale. Alcohol consumption 
was monitored during three consecutive weeks and average ethanol intake 
(g/kg), ethanol preference (% of total fluid intake) and total fluid consumption 
(ml/kg) per week were calculated and compared between strains and treatment 
groups.  
 
Statistical analysis 
SPSS 22.0 (Windows) was used for statistical analyses. qPCR data were 
analyzed per brain region (AMG, PFc, NAC) using multivariate ANOVA’s, with 
genotype as the between-subjects factor. Ethanol consumption data were 
analyzed by three-way repeated measures ANOVA with genotype and treatment 
as the between-subjects factors and time as the repeated measures within-
subjects factor. Post-hoc analysis was performed by t-tests where appropriate. 
Differences between pairs of means were considered significant at alpha < 0.05. 
All results are shown as mean ± S.E.M. values. 
 
Results 
Identification of candidate genes 
To narrow down the previously identified QTL for alcohol preference on mouse 
chromosome 2, we first identified, using the MGI Gene Query, a total of 369 
protein-coding genes within the QTL range (112-134 Mbp). Subsequently, 
haplotype mapping was performed using the Perlegen Genotype Browser to 
compare the haplotype blocks for the C57BL/6J and A/J host strains within the 
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QTL range (112-134 Mbp). With this approach, the QTL range was reduced to 20 
blocks with genetic variation between C57Bl/6J and A/J mice, leaving 168 
candidate genes (Figure 1). Thereafter, coding non-synonymous SNPs within the 
QTL range were identified using the MGI Mouse SNP Query, which resulted in a 
further reduction of the number of candidate genes to 52. Finally, we determined 
which genes within the QTL are expressed in brain tissue and may constitute 
part of the neuromolecular mechanism that controls alcohol consumption. The 
list of candidate genes was aligned with the nearly 20,000 genes expressed in 
the brain in accordance to Allen Brain Atlas (http://www.brain-map.org/). This 
reduced the list of candidate genes to a total of 43 genes (Table 2).  
 
To further narrow down the list of remaining candidate genes, the expression 
patterns of the remaining 43 genes were explored, thereby focusing on brain 
regions that have been associated with reward and addictive behavior, i.e. the 
PFc, AMG and NAc. For the majority of genes that remained based on their brain 
expression pattern (20 genes), there was no evidence for involvement in the 
modulation of behavior (http://www.informatics.jax.org). These genes were, for 
example, implicated in platelet regulation, leukemia, inner ear function and 
cancer. These genes were therefore discarded from our candidate gene list, 
leaving us with four genes that are expressed in reward-related brain regions 
(PFc, AMG and NAc) and have been implicated, directly or indirectly, in (reward-
related) behavior, i.e. Adal (Golembiowska and Zylewska, 2000), Chrm5 (Basile 
et al., 2002; Thomsen et al., 2005), Disp2 (Galli et al., 2014) and Ubr1 (Balogh 
et al., 2002).  
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Enhanced Adal and Chrm5 expression in brains of CSS-2 mice 
To assess whether Adal, Chrm5, Disp2 and Ubr1 are involved in alcohol 
preference, mRNA expression levels for these genes were compared in PFC, AMG 
and NAc of CSS-2 and C57BL/6J mice. Analysis of the data revealed an up-
regulation of Adal in CSS-2 versus C57BL/6J mice in all three brain regions: PFc 
(Fgenotype(1,11) = 30.4, P < 0.001), AMG (Fgenotype(1,11) = 5.7, P < 0.05) and NAc 
(Fgenotype(1,11) = 7.4, P < 0.05) (Figure 2). Ubr1 was up-regulated in the AMG of 
CSS-2 mice (Fgenotype(1,11) = 7.2, P < 0.05) while Chrm5 levels were increased in 
the PFc of the CSS-2 strain (Fgenotype(1,11) = 5.3, P < 0.05). Collectively, these 
data provide evidence for involvement of three of the identified candidate genes, 
in the phenotypic differences in alcohol consumption and preference between 
CSS-2 and C57BL/6J mice.  
 
Reversal of the CSS-2 alcohol preference phenotype by Adal inhibition 
Since of the 4 candidate genes, Adal was up-regulated in all regions examined 
(i.e. PFC, AMG and NAc) of CSS-2 mice, we next explored the functional role of 
Adal in regulating alcohol consumption in CSS-2 mice. For that purpose, we used 
the adenosine deaminase inhibitor EHNA (Nelson et al., 2009; Rosemberg et al., 
2007; Woodson et al., 1998), in order to counteract the putatively increased 
adenosine deaminase activity in CSS-2 mice. Animals of both strains were 
treated with either vehicle or EHNA prior to each daily alcohol consumption 
session. Alcohol intake increased over time (Ftime(2,54) = 29.9, P < 0.001), 
indicative of escalation of alcohol intake as we have reported previously 
(Lesscher et al., 2009a; Lesscher et al., 2012). In agreement with previous 
findings, the CSS-2 mice showed lower levels of alcohol intake (Fgenotype(1,27) 
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=29.5, P < 0.001; Ftime x genotype (2,54) = 18.2, P < 0.001), and lower alcohol 
preference when compared to C57BL/6J mice (Fgenotype(1,27) = 53.4, P < 0.001), 
independent of time (Ftime x genotype (2,54) = 2.6, N.S., Figure 3) (Lesscher et al., 
2009a). There were no genotype differences in the total amount of fluid 
consumed (Fgenotype(1,27) = 0.48, N.S.; Ftime x genotype(2,54) = 0.32, N.S.).  
 
 
Analysis of the effects of EHNA treatment revealed a selective increase in 
alcohol preference in CSS-2 mice, partly reversing their preference phenotype to 
that of the C57BL/6J host strain (Figure 3). There was no overall effect of EHNA 
on alcohol preference (Ftreatment(1,27) = 1.3, N.S.). However, treatment with EHNA 
altered alcohol preference in a genotype-dependent manner (Fgenotype x treatment(1,27) 
= 5.9, P < 0.05). Post-hoc pairwise comparisons confirmed that EHNA increased 
alcohol preference in CSS-2 mice (P = 0.019) but did not affect alcohol 
preference in C57BL/6J mice (P = 0.366), supporting the functional contribution 
of Adal to the low alcohol preference phenotype of CSS-2 mice. Post-hoc 
pairwise comparisons by week revealed that EHNA increased alcohol preference 
in CSS-2 mice predominantly in weeks 2 and 3 of the experiment (wk1: P = 
0.066; wk2: P = 0.024; wk3: P = 0.043). Although EHNA increased alcohol 
preference in CSS-2 mice, the Adal inhibitor did not alter alcohol intake: there 
was no overall effect of treatment on alcohol intake (Ftreatment(1,27) = 0.17, N.S.), 
nor was there a genotype-dependent effect of this compound on alcohol intake 
(Fgenotype x treatment(2,54) = 0.3, N.S.). Importantly, EHNA did not affect total fluid 
consumption (Ftreatment(1,26) = 0.06, N.S.; Fgenotype x treatment(1,26) = 1.4, N.S.), ruling 
out aspecific effects on thirst or fluid ingestion. Moreover, there were no 
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differences in body weight across the experiment for the genotypes or treatment 
groups (Fgenotype (1,27) =0.46, N.S.; Ftime x genotype (2,54) = 2.1, N.S.; Ftreatment(1,27) = 
0.17, N.S.; Fgenotype x treatment(1,27) = 1.8, N.S.) (data not shown). 
 
Discussion  
This study identifies Adal as an important candidate gene within a QTL for 
alcohol preference on mouse chromosome 2. Compared to C57BL/6J mice, Adal 
expression was enhanced in reward-related brain regions in the low alcohol 
preferring CSS-2 strain, and inhibition of Adal activity selectively increased 
alcohol preference in CSS-2 mice. 
 
Candidate genes identified within the alcohol preference QTL 
To identify candidate genes within the alcohol preference QTL, we applied 
criteria that have previously been used to distinguish candidate genes within a 
QTL: coding SNPs, gene expression patterns and gene function (Korstanje and 
Paigen, 2002; Nikolskiy et al., 2015; Noyes et al., 2011). A limitation of this 
approach is that potentially relevant genes are excluded because non-coding 
SNPs or other brain regions may also contribute to alcohol preference. Moreover, 
using this approach, only genes with a known function, i.e. based on available 
literature were selected, thus ruling out potential novel candidate genes. The 
previously identified QTL for alcohol preference was narrowed down to four 
candidate genes that have, directly or indirectly, been implicated in the 
modulation of reward sensitivity, i.e. Adal, Chrm5, Disp2 and Ubr1. Adenosine 
deaminase-like (Adal) belongs to the adenosine deaminase (Ada) family, based 
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on phylogenetic analyses (Maier et al., 2005; Rosemberg et al., 2007). Ethanol 
has been shown to inhibit Ada activity in rat forebrain (Sogut and Kanbak, 2010) 
and Ada inhibition reduced methamphetamine-induced dopamine release and 
stereotypy (Golembiowska and Zylewska, 2000). Chrm5 knockout mice show 
reduced morphine-induced conditioned place preference and cocaine self-
administration (Basile et al., 2002; Thomsen et al., 2005) and altered 
amphetamine- and morphine induced NAc dopamine release (Schmidt et al., 
2010). Disp2 is involved in hedgehog signaling that affects transcription of Wnt 
genes, which in turn are important for the development and maintenance of 
mesolimbic dopamine neurons and contribute to amphetamine-induced activity 
(Galli et al., 2014; Wurst and Prakash, 2014). Finally, Ubr1 null mice show 
reduced motor activity and impaired spatial learning (Balogh et al., 2002) that 
may also have implications for reward learning and substance addiction. 
 
 Differential expression of these genes between CSS-2 and C57BL/6J mice 
suggests that they contribute to the alcohol phenotype of CSS-2 mice, i.e. 
reduced alcohol consumption and preference compared to C57BL/6J mice 
(Lesscher et al., 2009a). Therefore, expression levels of Adal, Chrm5, Disp2 and 
Ubr1 were compared in brain regions that contribute to reward and 
addiction,,i.e. PFc, AMG and NAc (Everitt and Robbins, 2013; Koob and Volkow, 
2010; Tabakoff and Hoffman, 2013). We found that Adal expression was 
increased in all three regions in CSS-2 mice. In addition, the expression of Ubr1 
and Chrm5 was increased in the AMG and PFc of CSS-2 mice, respectively.  
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Adenosine and alcohol consumption  
Adenosine deaminase-like (Adal) belongs to the adenosine deaminase (Ada) 
family (Maier et al., 2005; Rosemberg et al., 2007). Adenosine deaminases are 
known to cleave, through deamination, adenosine into inosine, thereby reducing 
adenosine levels, although physiological evidence to confirm that Adal converts 
adenosine to inosine, as Ada does, is at present lacking. Mice of the CSS-2 strain 
showed enhanced expression of adenosine deaminase-like (Adal) in PFc, AMG 
and NAc. Enhanced Adal expression in CSS-2 mice therefore likely results in 
lower brain adenosine levels, which is associated with lower alcohol preference. 
Conversely, alcohol itself has been shown to inhibit Ada activity in rat forebrain 
(Sogut and Kanbak, 2010), which results in increased brain adenosine levels. 
Together, this suggests that increased forebrain adenosine activity stimulates 
alcohol intake. Indeed, inhibition of Ada using EHNA, thereby increasing 
adenosine levels, partially reversed the low alcohol preference phenotype of 
CSS-2 mice. In contrast, EHNA did not affect alcohol intake or preference in 
C57BL/6J mice, suggesting that a further increase in adenosine activity above 
baseline levels does not alter the effects of alcohol in this strain. Although we did 
not measure blood alcohol levels after the drinking sessions, the blood alcohol 
levels for CSS-2 mice are likely to be low. Thus, the question remains whether 
Adal influences the pharmacological effects of alcohol, or perhaps its rewarding 
or aversive effects. However, taste is not likely to account for the observed 
strain difference, and, hence, the effects of EHNA on alcohol preference, because 
previous studies did not reveal differences in taste sensitivity between CSS-2 
and C57BL/6J mice (Lesscher et al., 2009a). Together, these findings show that 
adenosine levels may determine the risk for or resilience to alcohol consumption 
and, ultimately, AUD.  
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The present findings somewhat contrast with previous work on adenosine 
signaling and alcohol consumption. That is, adenosine 2A receptor (A2A) null 
mutant mice show enhanced alcohol consumption (Houchi et al., 2008; Naassila 
et al., 2002) while treatment with an A2A agonist reduced alcohol intake (Houchi 
et al., 2013). In addition, alcohol consumption is enhanced in null mutants of 
one of the major transporters of adenosine in the brain, type 1 equilibrative 
nucleoside transporter (ENT) (e.g. Choi et al., 2004). There are several possible 
explanations for these seemingly discrepant findings. First, the increased 
sensitivity to alcohol reward in A2A null mice depends on the genetic 
background; it is only apparent on a CD1, but not a C57BL/6J background 
(Houchi et al., 2008). Second, because ENT is a bidirectional adenosine 
transporter, the adenosine dynamics of ENT knockout mice is very much 
different from CSS-2 mice, with presumably lower circulating adenosine. Third, 
an important difference with the studies by Houchi et al. (2008) and Naassila et 
al. (2002) is that we restricted access to alcohol to 2 hours each day, as 
opposed to using a 24h two-bottle choice paradigm. We report selective effects 
of genotype (C57BL/6J versus CSS-2) and EHNA on alcohol preference using this 
limited access paradigm. These findings agree with the selectivity of the 
previously identified QTL for alcohol preference (Lesscher et al., 2009a), 
suggesting that there is a genetic and neurobiological dissociation of alcohol 
preference and alcohol intake. Limited access paradigms result in higher levels 
of alcohol intake, but also in a clear preference for alcohol (e.g. Lesscher et al., 
2009a; 2012), which is often not evident when mice have continuous access to 
alcohol in 24h two-bottle choice tasks (e.g. Gill and Boyle, 2005; Hodge et al., 
1999; Nie et al., 2011; Peirce et al., 1998; Tarantino et al., 1998). Our current 
findings suggest that when access to alcohol is restricted, adenosine signaling 
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may selectively alter alcohol preference. Indeed, A2A knockout mice also show a 
selective increase in alcohol preference in the limited access paradigm whilst 
consuming similar levels of alcohol (Lesscher and Bailey, unpublished). Taken 
together, the current findings confirm the importance of adenosine signaling for 
alcohol drinking, although the precise mechanisms require further study.  
 
Actual adenosine levels, but also the dynamics of adenosine signaling may 
impact on behavior. Diurnal fluctuations in adenosine levels – low during sleep 
time while rising during wake time - have been proposed to contribute to day-
night cycling (Porkka-Heiskanen et al., 1997). Importantly, day-night cycling is a 
key factor in alcohol consumption by rodents. Limited-access paradigms 
(Lesscher et al., 2009a; 2012; Rhodes et al., 2005) employ the natural tendency 
of rodents to consume most of their fluids during the active phase, providing 
access to alcohol in the beginning of the dark cycle, when they consume most of 
their fluids (Dole and Gentry, 1984). It is therefore conceivable that altered 
adenosine dynamics may, by altering the sleep-wake-cycle, lead to the reduced 
alcohol preference alcohol observed in CSS-2 mice.  
 
Neurobiological mechanisms of adenosine modulation of alcohol reward 
Adenosine acts as a modulator of neurotransmission in the CNS, which may 
influence a variety of behaviors, including addictive behavior (Burnstock et al., 
2011). The effects of adenosine in the central nervous system are mediated 
through adenosine A1 and A2 receptors, the latter of which has been implicated 
in drug taking (Arolfo et al., 2004; Houchi et al., 2008; Naassila et al., 2002; 
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Thorsell et al., 2007). These adenosine receptors have been shown to interact 
with multiple receptor types, which allows adenosine to impact on a wide array 
of neurobiological systems and behaviors. For example, adenosine A2A receptors 
interact with dopamine D1 and D2 receptors, but also with A1 receptors and 
metabotropic glutamate receptors (e.g. Nam et al., 2013; Sebastiao and Ribeiro, 
2000), all of which have been implicated in addictive behavior (Dalley and 
Everitt, 2009; Fuxe et al., 2010; Hack and Christie, 2003; Pomierny-Chamiolo et 
al., 2014). Indeed, A2A and D2 receptors have been shown to synergistically 
regulate alcohol consumption (Yao et al., 2002). 
 
The elevation in Adal levels in CSS-2 mice versus C57BL/6J mice was 
observed in the PFc, AMG and NAc. These brain regions have been implicated in 
the transition to excessive alcohol use, which is a critical determinant of 
alcoholism (Darcq et al., 2014; George et al., 2012). The AMG, and in particular 
its central nucleus (CeA), is known to contribute to dependence-induced drinking 
(e.g. Funk et al., 2006; Gilpin et al., 2008; Pandey et al., 2008). Moreover, the 
CeA contributes to escalation of alcohol intake and the development of quinine 
resistant alcohol consumption (e.g. Lesscher et al., 2012). Finally, there is a 
substantial body of evidence implicating the nucleus accumbens in alcohol 
consumption (e.g. Cozzoli et al., 2012; Griffin et al., 2014; Hopf et al., 2011; 
Neasta et al., 2011). Thus, the observed up-regulation of Adal in CSS-2 mice in 
these brain regions likely contributes to the low alcohol preference of these 
animals. 
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Conclusion 
This study identified Adal as a genetically protective factor against alcohol 
preference drinking in mice, where elevated Adal levels contribute to low levels 
of alcohol intake. An intriguing question that remains to be addressed is 
whether, conversely, adenosine deaminase deficiencies increase an individuals’ 
propensity to consume alcohol. This is conceivable, since high alcohol drinking 
C57BL/6J mice (Rhodes et al., 2007) are considered to be a rodent model for 
AUD (for review see Hopf and Lesscher, 2014). Ada replacement therapies are 
used clinically, these have for example been used to successfully treat immune 
deficient patients, who suffer from Ada insufficiency (Brigida et al., 2014; 
Grunebaum et al., 2013). Ada replacement may therefore represent a strategy 
to treat AUD and perhaps other forms of addiction. Future studies, using 
clinically relevant models for AUD (Hopf et al., 2010; Lesscher et al., 2010; Seif 
et al., 2015; Spoelder et al., 2015; Vanderschuren et al., 2017) should 
investigate this possibility. 
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Figure Legends 
Figure 1 The QTL on mouse chromosome 2 for alcohol preference comprised a 
total of 369 genes. This number was reduced to 43 candidate genes through 
haplotype mapping, in silico SNP analysis and selection for brain expression. 
 
Figure 2 qPCR analysis comparing Adal, Chrm5, Disp2 and Ubr1 expression 
between strains. There was an up-regulation of Adal in CSS-2 versus C57BL/6J 
mice in PFc, AMG and NAc. In addition, Ubr1 mRNA levels were increased in 
CSS-2 in AMG and Chrm5 mRNA levels were higher in PFc of CSS-2 versus 
C57BL/6J mice. Shown are mean ± SEM. * P < 0.05; ** P < 0.01. 
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Figure 3 Adal inhibition by systemic administration of EHNA partly reversed the 
low alcohol preference phenotype of CSS-2 mice without affecting alcohol 
preference in C57BL/6J mice or alcohol intake and total fluid consumption. 
Shown are mean ± SEM. * P < 0.05. 
 
 
 
 
Table 1. Primer Sequences for qPCR validation of 
candidate genes  
Primer Fwd Primer Rev 
TTCTTGGCCTTGACCTCAGT CAGAGGCGCTAAGGAATGTC 
TCAGCCATCAAATGACC
AAA 
AGTAACCCAAGTGCCACAGG 
CTGGCCTTCATCTTCCTCTG GGAGGCTTGAGCTGTTC
ATC 
ACTCCGTGGTTATGGCT
CAC 
AGGATCTTACGGGCACCTTT 
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Table 2. Candidate genes identified in the alcohol preference QTL on mouse 
chromosome 2.  
Adal adenosine deaminase-like 
Ap4e1 adaptor-related protein complex AP-4, epsilon 1 
Arhgap11a Rho GTPase activating protein 11A 
B2m beta-2 microglobulin 
Blvra biliverdin reductase A 
Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) 
Casc5 cancer susceptibility candidate 5 
Catsper2 cation channel, sperm associated 2 
Ccndbp1 cyclin D-type binding-protein 1 
Cdan1 congenital dyserythropoietic anemia, type I (human) 
Chac1 ChaC, cation transport regulator-like 1 (E. coli) 
Chrm5 cholinergic receptor, muscarinic 5 
Ctdspl2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 
Disp2 dispatched homolog 2 (Drosophila) 
Dll4 delta-like 4 (Drosophila) 
Dnajc17 DnaJ (Hsp40) homolog, subfamily C, member 17 
Duoxa1 dual oxidase maturation factor 1 
Epb4.2 erythrocyte protein band 4.2 
Fsip1 fibrous sheath-interacting protein 1 
Hisppd2a histidine acid phosphatase domain containing 2A 
Itpka inositol 1,4,5-trisphosphate 3-kinase A 
Lcmt2 leucine carboxyl methyltransferase 2 
Ltk leukocyte tyrosine kinase 
Mapkbp1 mitogen-activated protein kinase binding protein 1 
Mga MAX gene associated 
Mtap1a microtubule-associated protein 1 A 
Ndufaf1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1 
Nusap1 nucleolar and spindle associated protein 1 
Pak6 p21 (CDKN1A)-activated kinase 6 
Pla2g4b phospholipase A2, group IVB (cytosolic) 
Plcb2 phospholipase C, beta 2 
Pldn Pallidin 
Rpap1 RNA polymerase II associated protein 1 
Slc30a4 solute carrier family 30 (zinc transporter), member 4 
Strc Stereocilin 
Trp53bp1 transformation related protein 53 binding protein 1 
Ubr1 ubiquitin protein ligase E3 component n-recognin 1 
Zfyve19 zinc finger, FYVE domain containing 19 
2310003F16Rik RIKEN cDNA 2310003F16 gene 
6330405D24Rik RIKEN cDNA 6330405D24 gene 
A430105I19Rik RIKEN cDNA A430105I19 gene 
A530010F05Rik RIKEN cDNA A530010F05 gene 
A530057A03Rik RIKEN cDNA A530057A03 gene 
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